Delayed Medicines To Hit Irish Market, But Uncertainty Remains For Future

Nine new approved treatments that have faced delays in getting to Irish patients should hit the market this year, says the Health Service Executive. The innovative pharmaceutical industry welcomes the move but is calling for clear political direction on future processes.